Stay updated with breaking news from Luke schmerold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Helsinn publishes results from a secondary analysis of a Phase 3 trial in patients with CINV in The Oncologist Lugano, Switzerland, January 4, 2023 - Helsinn Group ("Helsinn") ....